TO-507

N/A

Report date: 2025/01/26 16:54:51
NME

Base Information

Drug NameTO-507
Drug Alias Namensp14 methyltransferase inhibitors (Institute of Organic Chemistry and Biochemistry/Gilead Sciences/University of Chemistry and Technology Prague/University of Toronto)TO-507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesVysoka Skola Chemicko-Technologicka v PrazeUniversity of TorontoInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences +[4] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A